Tradename | Company | Number | Date | Products |
---|---|---|---|---|
PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE | Baxter | N-217512 RX | 2024-02-14 | 3 products, RLD, RS |
PANTOPRAZOLE SODIUM | Hikma Pharmaceuticals | N-209463 RX | 2017-06-30 | 1 products, RLD, RS |
PROTONIX | WYETH PHARMS | N-020987 RX | 2000-02-02 | 2 products, RLD, RS |
PROTONIX IV | WYETH PHARMS | N-020988 RX | 2001-03-22 | 1 products, RLD, RS |
PROTONIX | WYETH PHARMS | N-022020 RX | 2007-11-14 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
antiseptic skin cleanser | New Drug Application | 2024-02-13 |
rugby petrolatum hydrating | C200263 | 2024-02-12 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 37 | 3 | — | 4 | 9 | 52 |
Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | 6 | 3 | 19 | 11 | 13 | 51 |
Covid-19 | D000086382 | — | U07.1 | 2 | 8 | 4 | 5 | 14 | 31 |
Infections | D007239 | EFO_0000544 | — | 2 | 2 | 3 | 6 | 13 | 25 |
Tooth discoloration | D014075 | — | K03.6 | — | — | — | 3 | 10 | 13 |
Tooth bleaching | D014073 | — | — | 1 | — | 2 | 3 | 6 | 12 |
Coronary artery disease | D003324 | — | I25.1 | — | 1 | — | 8 | 2 | 11 |
Peptic ulcer | D010437 | HP_0004398 | K27 | 1 | — | 5 | 2 | 3 | 11 |
Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | 1 | — | 1 | 2 | 7 | 11 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 7 | 1 | 1 | — | 9 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Colorectal neoplasms | D015179 | — | — | 1 | 11 | 2 | — | 2 | 15 |
Parkinson disease | D010300 | EFO_0002508 | G20 | 6 | 2 | 2 | — | 2 | 10 |
Peri-implantitis | D057873 | EFO_1001390 | — | 1 | — | 1 | — | 5 | 7 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 1 | 1 | 2 | — | 2 | 6 |
Neurofibromatosis 1 | D009456 | — | Q85.01 | 1 | 5 | 1 | — | — | 6 |
Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | — | 1 | — | 5 | 6 |
Aging | D000375 | GO_0007568 | R41.81 | — | — | 1 | — | 5 | 6 |
Vomiting | D014839 | HP_0002013 | R11.1 | 1 | 2 | 2 | — | — | 5 |
Hiv infections | D015658 | EFO_0000764 | B20 | 1 | 1 | 3 | — | — | 5 |
Glioma | D005910 | EFO_0000520 | — | — | 3 | 1 | — | 1 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neoplasms | D009369 | — | C80 | 6 | 4 | — | — | 4 | 13 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 1 | 6 | — | — | — | 7 |
Asthma | D001249 | EFO_0000270 | J45 | 1 | 1 | — | — | 5 | 6 |
Prostatic neoplasms | D011471 | — | C61 | — | 5 | — | — | — | 5 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 5 | — | — | — | 5 |
Head and neck neoplasms | D006258 | — | — | — | 3 | — | — | 2 | 5 |
Stroke | D020521 | EFO_0000712 | I63.9 | 1 | 1 | — | — | 3 | 5 |
Urinary bladder neoplasms | D001749 | — | C67 | — | 3 | — | — | — | 3 |
Esophageal neoplasms | D004938 | — | C15 | — | 3 | — | — | — | 3 |
Lymphoma | D008223 | — | C85.9 | — | 3 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | — | — | — | 3 | 4 |
Dental caries | D003731 | EFO_0003819 | K02 | 1 | — | — | — | 2 | 3 |
Bacterial infections | D001424 | — | A49 | 2 | — | — | — | 1 | 3 |
Atopic dermatitis | D003876 | EFO_0000274 | L20 | 1 | — | — | — | 2 | 3 |
Anesthesia | D000758 | — | — | 1 | — | — | — | 1 | 2 |
Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 1 | — | — | — | 1 | 2 |
Fasting | D005215 | EFO_0002756 | — | 1 | — | — | — | 1 | 2 |
Septic shock | D012772 | — | A48.3 | 1 | — | — | — | 1 | 2 |
Wound healing | D014945 | GO_0042060 | — | 1 | — | — | — | 1 | 2 |
Colic | D003085 | HP_0011848 | R10.83 | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Refractive errors | D012030 | EFO_0003908 | H52.7 | — | — | — | — | 21 | 21 |
Myopia | D009216 | EFO_0003927 | H52.1 | — | — | — | — | 13 | 13 |
Oxidative stress | D018384 | EFO_1001905 | — | — | — | — | — | 7 | 7 |
Gestational diabetes | D016640 | HP_0009800 | O24.4 | — | — | — | — | 7 | 7 |
Hyperopia | D006956 | EFO_0006310 | H52.0 | — | — | — | — | 5 | 5 |
Astigmatism | D001251 | EFO_0004222 | H52.2 | — | — | — | — | 5 | 5 |
Presbyopia | D011305 | — | H52.4 | — | — | — | — | 4 | 4 |
Knee osteoarthritis | D020370 | EFO_0004616 | M17 | — | — | — | — | 4 | 4 |
Female urogenital diseases | D052776 | — | — | — | — | — | — | 3 | 3 |
Gastrointestinal diseases | D005767 | — | — | — | — | — | — | 3 | 3 |
Drug common name | Pantoprazole |
INN | pantoprazole |
Description | Pantoprazole is a member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2. It has a role as an anti-ulcer drug, an EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor, a xenobiotic and an environmental contaminant. It is a member of benzimidazoles, a member of pyridines, an aromatic ether, an organofluorine compound and a sulfoxide. It is a conjugate acid of a pantoprazole(1-). |
Classification | Small molecule |
Drug class | antiulcer agents (benzimidazole derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC |
PDB | — |
CAS-ID | 102625-70-7 |
RxCUI | — |
ChEMBL ID | CHEMBL1502 |
ChEBI ID | 7915 |
PubChem CID | 4679 |
DrugBank | DB00213 |
UNII ID | D8TST4O562 (ChemIDplus, GSRS) |